Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000929624-00-000361
Filing Date
2000-03-16
Accepted
2000-03-16 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D - AMENDMENT #1 SC 13D/A 9257
  Complete submission text file 0000929624-00-000361.txt   11382
Mailing Address 2033 GATEWAY PLACE SUITE 600 SAN JOSE CA 95110
Business Address 2033 GATEWAY PLACE SUITE 600 SAN JOSE CA 95110 4089882500
CELTRIX PHARMACEUTICALS INC (Subject) CIK: 0000871395 (see all company filings)

EIN.: 943121462 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-41502 | Film No.: 571371
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O COBLENTZ PATCH DUFFY & BASS LLP 222 KEARNY STREET 7TH FLOOR SAN FRANCISCO CA 94108
Business Address C/O COBLENTZ PATCH DUFFY & BASS LLP 222 KEARNEY STREET 7TH FLOOR SAN FRANCISCO CA 94108
VERON INTERNATIONAL LTD (Filed by) CIK: 0001019354 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8